Biodegradable nanoassemblies of piperlongumine display enhanced anti-angiogenesis and anti-tumor activities
Author:
Affiliation:
1. State Key Laboratory of Biotherapy
2. West China Hospital
3. West China Medical School
4. Sichuan University
5. Chengdu, PR China
6. Key Laboratory of Drug Targeting and Drug Delivery System
7. Ministry of Education
Abstract
Piperlongumine was rendered into polymeric micelles to form nanoassemblies, which significantly suppressed tumor growth and prolonged the survival of tumor-bearing mice.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science
Link
http://pubs.rsc.org/en/content/articlepdf/2014/NR/C3NR06599E
Reference46 articles.
1. Selective killing of cancer cells by a small molecule targeting the stress response to ROS
2. Reactive oxygen species in cancer cells: Live by the sword, die by the sword
3. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate
4. AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lipid‐Coated Mesoporous Silica Nanoparticles for pH‐Responsive Release and Enhanced Anti‐Proliferative Activity of Piperlongumine Natural Product;ChemistrySelect;2024-08-22
2. Curcumin-Piperlongumine Hybrid Molecule Increases Cell Cycle Arrest and Apoptosis in Lung Cancer through JNK/c-Jun Signaling Pathway;Journal of Agricultural and Food Chemistry;2024-03-22
3. Inhibition of the thioredoxin system for radiosensitization therapy of cancer;European Journal of Medicinal Chemistry;2024-03
4. Phytochemicals Showing Antiangiogenic Effect in Pre-clinical Models and their Potential as an Alternative to Existing Therapeutics;Current Topics in Medicinal Chemistry;2023-10-20
5. A strategy to improve the solubility and bioavailability of the insoluble drug piperlongumine through albumin nanoparticles;PAK J PHARM SCI;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3